Abstract

BackgroundCRISPR has been becoming a hot topic as a powerful technique for genome editing for human and other higher organisms. The original CRISPR-Cas (Clustered Regularly Interspaced Short Palindromic Repeats coupled with CRISPR-associated proteins) is an important adaptive defence system for prokaryotes that provides resistance against invading elements such as viruses and plasmids. A CRISPR cassette contains short nucleotide sequences called spacers. These unique regions retain a history of the interactions between prokaryotes and their invaders in individual strains and ecosystems. One important ecosystem in the human body is the human gut, a rich habitat populated by a great diversity of microorganisms. Gut microbiomes are important for human physiology and health. Metagenome sequencing has been widely applied for studying the gut microbiomes. Most efforts in metagenome study has been focused on profiling taxa compositions and gene catalogues and identifying their associations with human health. Less attention has been paid to the analysis of the ecosystems of microbiomes themselves especially their CRISPR composition.ResultsWe conducted a preliminary analysis of CRISPR sequences in a human gut metagenomic data set of Chinese individuals of type-2 diabetes patients and healthy controls. Applying an available CRISPR-identification algorithm, PILER-CR, we identified 3169 CRISPR cassettes in the data, from which we constructed a set of 1302 unique repeat sequences and 36,709 spacers. A more extensive analysis was made for the CRISPR repeats: these repeats were submitted to a more comprehensive clustering and classification using the web server tool CRISPRmap. All repeats were compared with known CRISPRs in the database CRISPRdb. A total of 784 repeats had matches in the database, and the remaining 518 repeats from our set are potentially novel ones.ConclusionsThe computational analysis of CRISPR composition based contigs of metagenome sequencing data is feasible. It provides an efficient approach for finding potential novel CRISPR arrays and for analysing the ecosystem and history of human microbiomes.Electronic supplementary materialThe online version of this article (doi:10.1186/s12918-015-0248-x) contains supplementary material, which is available to authorized users.

Highlights

  • clustered regularly interspaced short palindromic repeats (CRISPR) has been becoming a hot topic as a powerful technique for genome editing for human and other higher organisms

  • Comparing our findings with the ones from Gogleva et al [21] on gut samples of from 124 European individuals, downloaded as an assembly of 1,889,651 contigs with a total size of 3732 Mb, the most similar dataset to the one we used in terms of data size, we found that the number of CRISPR cassettes predicted by PILER-CR in our work was Metagenomic Type-2 diabetic Healthy dataset group individuals individuals

  • Applying CRISPRmap to our identified CRISPR repeats we found that 670 repeats were attributed superclasses, while the remaining 632 repeats were not assigned to any superclass

Read more

Summary

Introduction

CRISPR has been becoming a hot topic as a powerful technique for genome editing for human and other higher organisms. A CRISPR cassette contains short nucleotide sequences called spacers. These unique regions retain a history of the interactions between prokaryotes and their invaders in individual strains and ecosystems. The human body is host to this complex community of symbiotic, pathogenic and commensal microorganisms (microbiome), whose abundance is estimated to exceed the number of human cells by at least an order of magnitude [1]. Metagenomic sequencing has been proven to be a powerful tool for analysing complex microbial communities. In this context many projects have been developed all over the world to study human microbiomes of multiple body sites. The US-based Human Microbiome Project (HMP) [3] and the EU-based MetaHIT project [4] have generated resources that can enable the comprehensive characterization of the human microbiome and analysis of its role in human health and disease

Methods
Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.